Literature DB >> 1282933

The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein.

L H van den Berg1, S A Sadiq, S Lederman, N Latov.   

Abstract

We investigated the binding of the gp120 glycoprotein of the human immunodeficiency virus (HIV-1) to neural glycolipids and glycoproteins by ELISA. The gp120 protein bound to sulfatide (GalS), a sulfated glycolipid autoantigen implicated in sensory neuritis, and to the myelin associated glycoprotein (MAG), an autoantigen in demyelinating neuropathy. Binding of gp120 to MAG was inhibited by the HNK-1 antibody, which recognizes a sulfated glucuronic acid epitope, suggesting that the interaction involves carbohydrate determinants. Sulfatide and MAG are potential receptors for gp120 in peripheral nerve and may have a role in the neuropathy associated with HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282933     DOI: 10.1002/jnr.490330403

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Bilayer properties of totally synthetic C16:0-lactosyl-ceramide.

Authors:  K Saxena; P Zimmermann; R R Schmidt; G G Shipley
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Mixing properties of sphingomyelin ceramide bilayers: a simulation study.

Authors:  Rainer Metcalf; Sagar A Pandit
Journal:  J Phys Chem B       Date:  2012-04-06       Impact factor: 2.991

3.  Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication.

Authors:  T Glück; E Degenhardt; J Schölmerich; B Lang; J Grossmann; R H Straub
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

4.  Conformation of sulfoquinovosyldiacylglycerol bound to a magnetically oriented membrane system.

Authors:  K P Howard; J H Prestegard
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

5.  Unusual hydration properties of C16:0 sulfatide bilayer membranes.

Authors:  K Saxena; R I Duclos; P K Sripada; G G Shipley
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

Review 6.  Neuromuscular diseases associated with HIV-1 infection.

Authors:  Jessica Robinson-Papp; David M Simpson
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

7.  Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Authors:  Richard D Kensinger; Bradley J Catalone; Fred C Krebs; Brian Wigdahl; Cara-Lynne Schengrund
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 8.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

9.  Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.

Authors:  D Long; J F Berson; D G Cook; R W Doms
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 10.  Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS.

Authors:  S V Tan; R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.